Cas:121086-26-8 1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene manufacturer & supplier

Chemical Name:1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene

CAS.NO:121086-26-8

Synonyms:2-Nitro-5-methoxy-4-benzyloxy-toluol;4-BENZYLOXY-5-METHOXY-2-NITROTOLUENE;6-Nitro-kreosol-benzylaether;4-Benzyloxy-5-methoxy-2-nitro-toluol

Molecular Formula:C₁₅H₁₅NO₄

Molecular Weight:273.28400

HS Code:

Physical and Chemical Properties:

Melting point:122-124ºC

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:64.28000

Exact Mass:273.10000

LogP:4.01400

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Nitro-5-methoxy-4-benzyloxy-toluol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Benzyloxy-5-methoxy-2-nitro-toluol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-BENZYLOXY-5-METHOXY-2-NITROTOLUENE Use and application,6-Nitro-kreosol-benzylaether technical grade,usp/ep/jp grade.

Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances. 1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene manufacturer Our quality control staff then conducts analyses in the testing laboratory to examine whether the API manufactured is ultrapure. 1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene supplier ��With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.�� 1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene vendor With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce. 1-methoxy-5-methyl-4-nitro-2-phenylmethoxybenzene factory At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.